Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
Request a FREE Sample of our FcRn Binding Kit!
Request a FREE Sample of our Fc gamma RI / CD64 Binding Kit !
Happy Holiday! Limited Keychain here with your next orderHappy Holiday! Limited Keychain here with your next order
Request a FREE sample of our GMP products! Request a FREE sample of our GMP products!
| Cat. No. | Species | Product Description | Structure | Purity | Feature |
|---|---|---|---|---|---|
| RB1-HF2H7 | Human | FITC-Labeled Human ROBO1 Protein, His Tag |  |
|
|
| RB1-H82E5 | Human | Biotinylated Human ROBO1 Protein, His,Avitag™ (MALS verified) |  |
|
|
| RB1-H52H3 | Human | Human ROBO1 Protein, His Tag (MALS verified) |  |
|
|
2e5 of Anti-ROBO1 CAR-293 cells were stained with 100 μL of 10 μg/mL of FITC-Labeled Human ROBO1, His Tag (Cat. No. RB1-HF2H7) and negative control protein respectively, FITC signals was used to evaluate the binding activity (QC tested).
Immobilized Anti-ROBO1 Antibody, Mouse IgG1 at 1 μg/mL (100 μL/well) can bind Biotinylated Human ROBO1, His,Avitag (Cat. No. RB1-H82E5) with a linear range of 2-31 ng/mL (QC tested).
The purity of Biotinylated Human ROBO1, His,Avitag (Cat. No. RB1-H82E5) is more than 90% and the molecular weight of this protein is around 100-122 kDa verified by SEC-MALS.
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| BiCAR-NK/T cell therapy (Asclepius Technology Company Group (Suzhou) Co., Ltd) | Phase 2 Clinical | Asclepius Technology Company Group | Neoplasms | Details | |
| ROBO1 CAR-NK cell therapy (Asclepius Technology Company Group (Suzhou) Co., Ltd.) | Phase 2 Clinical | Asclepius Technology Company Group | Solid tumours; Pancreatic Neoplasms | Details | |
| BiCAR-NK/T cell therapy (Asclepius Technology Company Group (Suzhou) Co., Ltd) | Phase 2 Clinical | Asclepius Technology Company Group | Neoplasms | Details | |
| ROBO1 CAR-NK cell therapy (Asclepius Technology Company Group (Suzhou) Co., Ltd.) | Phase 2 Clinical | Asclepius Technology Company Group | Solid tumours; Pancreatic Neoplasms | Details |
This web search service is supported by Google Inc.
A-Z
